The pharmaceutical start-up company located in Erlangen/Regensburg researches and develops steroidal medicines for breast cancer and benign enlargement of the prostate gland. Curadis GmbH was founded in 2008 in Erlangen and has S-Refit AG of Regensburg as one of its investors. The company
is developing a novel substance for breast cancer and a substance for prostate cancer.

Contact Information

Merian Strasse 26
Nuremberg 90409


Total FundingEmployeesLast Funding DateStatus